Our Pricing

Individual Weight Loss Pen Supply: Flexible Prescription Options

Published on: June 03, 2026

When you buy kwik pen single dose UK options, you gain flexibility to trial treatments or manage your weight loss journey at your own pace. Cured Pharmacy offers individual pen supply for Mounjaro, Wegovy, and Saxenda, with transparent pricing from £135.00 and free clinical assessment by UK-registered prescribers.

What Is a KwikPen Single Dose Supply?

A KwikPen is a pre-filled injection device containing a single strength of medication, designed for subcutaneous administration. The term 'single dose' refers to purchasing individual pens rather than multi-pen packs, giving you greater control over treatment initiation and continuation [1].

This approach suits patients who want to trial a weight loss injection before committing to larger supplies, those transitioning between dose strengths, or individuals preferring flexible prescription schedules. All KwikPen devices available through UK pharmacies—including Mounjaro tirzepatide pens, Wegovy semaglutide pens, and Saxenda liraglutide pens—require clinical assessment by a UK prescriber before dispensing [2].

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team ensure every prescription meets MHRA safety standards whilst offering competitive pricing across our weight loss injection range.

Mounjaro KwikPen: Tirzepatide Single Pen Options

Mounjaro KwikPens are available in five dose strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Treatment typically begins at 2.5mg once weekly for four weeks, with gradual dose escalation as tolerated under prescriber guidance [1].

Purchasing individual pens allows patients to obtain precisely the doses prescribed during titration phases without committing to multi-month supplies. This flexibility proves particularly valuable during the initial 12-16 week escalation period when dose adjustments are most frequent.

How Mounjaro Tirzepatide Works

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for chronic weight management. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, producing enhanced metabolic effects [3].

In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 20.9% at the 15mg maintenance dose over 72 weeks—the highest reduction observed in any obesity medication trial to date [3]. Individual results vary based on adherence, diet, physical activity, and metabolic factors.

Wegovy and Saxenda: Alternative Injectable Options

Saxenda delivers liraglutide, an earlier-generation GLP-1 agonist requiring daily rather than weekly administration. Each Saxenda pen contains 18mg total medication, providing 30 doses at the 0.6mg starting strength or 6 doses at the 3mg maintenance level [2].

Daily injection schedules suit some patients better than weekly protocols, particularly those who prefer consistent daily routines or experience side effects with higher once-weekly doses. Clinical trials showed average weight loss of 8% over 56 weeks with Saxenda, lower than newer agents but still clinically meaningful when combined with lifestyle modifications [2].

Wegovy Semaglutide Single Pens

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone to reduce appetite and improve glycaemic control. The STEP 1 trial demonstrated average body weight reductions of 14.9% over 68 weeks at the 2.4mg maintenance dose [4].

Wegovy pens are available in escalating doses: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg. Like Mounjaro, treatment follows a gradual dose escalation protocol to minimise gastrointestinal side effects, which affect approximately 44% of users during initial weeks [4].

Buy Kwik Pen Single Dose: Clinical Considerations

Common side effects include nausea (affecting 18-44% of users), diarrhoea, constipation, vomiting, and abdominal discomfort, typically most pronounced during dose escalation phases and diminishing with continued use [3][4]. Rare but serious risks include pancreatitis, gallbladder disease, and hypoglycaemia when combined with insulin or sulfonylureas.

Single pen purchasing allows patients to pause treatment if side effects become intolerable, restart at lower doses, or discontinue without financial commitment to unused multi-pen packs. This flexibility supports safer, more personalised weight management under ongoing prescriber supervision.

Who Can Use Weight Loss Injection Pens?

NICE guidelines recommend GLP-1 receptor agonists for adults with BMI ≥30 kg/m², or BMI ≥27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Your UK prescriber will assess your medical history, current medications, and weight loss goals during consultation [5].

These treatments are contraindicated in pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. Patients with diabetic retinopathy, pancreatitis history, or renal impairment require careful evaluation before initiation [1][3].

How to Order Individual Weight Loss Pens Online

All prescription weight loss injections require clinical assessment by a UK-registered prescriber before dispensing. At Cured Pharmacy, the process takes under three minutes: complete our online medical questionnaire, receive prescriber review within hours, and choose discreet home delivery or click-and-collect from our GPhC-registered premises (9012511).

We display transparent upfront pricing before consultation—no hidden fees or subscription traps. You'll see exactly what each pen costs, with clear information about dose escalation schedules and typical treatment duration. Our clinical team provides injection technique guidance, storage instructions, and ongoing support throughout your weight loss journey.

Once your prescription is approved, we dispense only genuine UK-licensed medications sourced directly from licensed wholesalers. Every pen arrives in 100% discreet packaging with temperature-controlled shipping to maintain medication integrity. Most orders reach patients within 1-3 working days across the UK.

Single Pen Supply vs Multi-Pen Packs: Which Suits You?

Multi-pen packs typically offer per-unit cost savings but require larger upfront investment and commitment to specific dose strengths. If you're confident in your treatment choice, tolerate the medication well, and have reached maintenance dosing, bulk purchasing may reduce overall expenditure.

At Cured Pharmacy, we support both approaches. Our clinical team helps you determine the most cost-effective and medically appropriate supply schedule based on your treatment stage, tolerance, and financial preferences. You're never locked into purchasing patterns that don't serve your health goals.

Advantages of Individual Pen Purchasing

Buying single pens offers maximum flexibility during treatment initiation and dose adjustment phases. You avoid paying upfront for doses you may not tolerate, can pause treatment without wasting unused pens, and easily switch between medications if your prescriber recommends an alternative approach.

This model particularly benefits patients trialling weight loss injections for the first time, those with limited budgets preferring pay-as-you-go arrangements, or individuals whose insurance or workplace schemes reimburse per-prescription rather than in bulk.

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14443 [accessed 13 August 2026]
2. Electronic Medicines Compendium. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen: Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/2313 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and physical activity levels.